{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:44:57Z","timestamp":1773805497316,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.6061\/clinics\/2015(02)05","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T15:12:13Z","timestamp":1426518733000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism"],"prefix":"10.1016","volume":"70","author":[{"given":"Oktay","family":"Bilgir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferda","family":"Bilgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Calan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem Gursoy","family":"Calan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.6061\/clinics\/2015(02)05_bib1","first-page":"209","article-title":"Thyroid failure in the elderly","volume":"258","author":"Rosenthal","year":"1987","journal-title":"Microsomal antibodies as discriminant for therapy. JAMA"},{"issue":"6","key":"10.6061\/clinics\/2015(02)05_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.6061\/clinics\/2015(02)05_bib3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.160.11.1573","article-title":"American Thyroid Association guidelines for detection of thyroid dysfunction","volume":"160","author":"Ladenson","year":"2000","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.6061\/clinics\/2015(02)05_bib4","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1210\/jcem.86.10.7959","article-title":"Subclinical hypothyroidism is mild thyroid failure and should be treated","volume":"86","author":"McDermott","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.6061\/clinics\/2015(02)05_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.6061\/clinics\/2015(02)05_bib6","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1210\/jcem.82.10.4296","article-title":"Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism","volume":"82","author":"Monzani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.6061\/clinics\/2015(02)05_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2265.1999.00790.x","article-title":"Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy","volume":"51","author":"Monzani","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.6061\/clinics\/2015(02)05_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.1995.5.283","article-title":"Peripheral neuropathy in subclinical hypothyroidism","volume":"5","author":"Misiunas","year":"1995","journal-title":"Thyroid"},{"issue":"11","key":"10.6061\/clinics\/2015(02)05_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1089\/thy.1998.8.1029","article-title":"Serum creatine kinase levels in overt and subclinical hypothyroidism","volume":"8","author":"Beyer","year":"1998","journal-title":"Thyroid"},{"issue":"8","key":"10.6061\/clinics\/2015(02)05_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/10507250050137743","article-title":"Cardiovascular and atherogenic aspects of subclinical hypothyroidism","volume":"10","author":"Kahaly","year":"2000","journal-title":"Thyroid"},{"issue":"5","key":"10.6061\/clinics\/2015(02)05_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/thy.1996.6.397","article-title":"Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy","volume":"6","author":"Arem","year":"1996","journal-title":"Thyroid"},{"issue":"1","key":"10.6061\/clinics\/2015(02)05_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2265.1985.tb01068.x","article-title":"End-organ responses to thyroxine therapy in subclinical hypothyroidism","volume":"22","author":"Bell","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.6061\/clinics\/2015(02)05_bib13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/jcem.86.3.7291","article-title":"Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study","volume":"86","author":"Monzani","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"10.6061\/clinics\/2015(02)05_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.6061\/clinics\/2015(02)05_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/CS20120542","article-title":"Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients","volume":"125","author":"Kahraman","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"14","key":"10.6061\/clinics\/2015(02)05_bib16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.105.588723","article-title":"Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study","volume":"113","author":"Ix","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.6061\/clinics\/2015(02)05_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/diacare.29.02.06.dc05-1484","article-title":"Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects","volume":"29","author":"Mori","year":"2006","journal-title":"Diabetes Care"},{"issue":"10","key":"10.6061\/clinics\/2015(02)05_bib18","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/db08-0538","article-title":"Plasma fetuin-A levels and the risk of type 2 diabetes","volume":"57","author":"Stefan","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.6061\/clinics\/2015(02)05_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12020-013-9993-z","article-title":"Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism","volume":"45","author":"Bilgir","year":"2014","journal-title":"Endocrine"},{"issue":"8","key":"10.6061\/clinics\/2015(02)05_bib20","first-page":"439","article-title":"High-sensitivity C-reactive protein: clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr Probl Cardiol"},{"issue":"16","key":"10.6061\/clinics\/2015(02)05_bib21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.6061\/clinics\/2015(02)05_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","article-title":"Inflammatory bio-markers and cardiovascular risk prediction","volume":"252","author":"Blake","year":"2002","journal-title":"J Intern Med"},{"issue":"9","key":"10.6061\/clinics\/2015(02)05_bib23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.102.9.1000","article-title":"Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease","volume":"102","author":"Fichtlscherer","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.6061\/clinics\/2015(02)05_bib24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1536\/ihj.46.801","article-title":"Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome","volume":"46","author":"Kokturk","year":"2005","journal-title":"Int Heart J"},{"issue":"5","key":"10.6061\/clinics\/2015(02)05_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.6061\/clinics\/2015(02)05_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","article-title":"C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"issue":"50","key":"10.6061\/clinics\/2015(02)05_bib27","doi-asserted-by":"crossref","first-page":"31496","DOI":"10.1074\/jbc.272.50.31496","article-title":"Cloning and targeted deletion of the mouse fetuin gene","volume":"272","author":"Jahnen-Dechent","year":"1997","journal-title":"J Biol Chem"},{"issue":"22","key":"10.6061\/clinics\/2015(02)05_bib28","doi-asserted-by":"crossref","first-page":"19991","DOI":"10.1074\/jbc.M112234200","article-title":"alpha 2-HS glycoprotein\/fetuin, a transforming growth factor-beta\/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling","volume":"277","author":"Szweras","year":"2002","journal-title":"J Biol Chem"},{"issue":"9360","key":"10.6061\/clinics\/2015(02)05_bib29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"issue":"15","key":"10.6061\/clinics\/2015(02)05_bib30","first-page":"13333","article-title":"Structural basis of calcification inhibition by alpha 2-HS glycoprotein\/fetuin-A","volume":"278","author":"Heiss","year":"2003","journal-title":"Formation of colloidal calciprotein particles. J Biol Chem"},{"issue":"3","key":"10.6061\/clinics\/2015(02)05_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/CS20030126","article-title":"Fetuin\/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages","volume":"105","author":"Jersmann","year":"2003","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.6061\/clinics\/2015(02)05_bib32","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2004100895","article-title":"Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification","volume":"16","author":"Reynolds","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.6061\/clinics\/2015(02)05_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.jrn.2007.10.017","article-title":"Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease","volume":"18","author":"Ku\u017aniar","year":"2008","journal-title":"J Ren Nutr"},{"issue":"2","key":"10.6061\/clinics\/2015(02)05_bib34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2265.2006.02716.x","article-title":"Association of serum fetuin-A with carotid arterial stiffness","volume":"66","author":"Mori","year":"2007","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222008018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222008018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-70-02\/cln-70-02-097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:53:13Z","timestamp":1761720793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222008018"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322015000200097&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4351305\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1807593222008018"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2015(02)05","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2015(02)05","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}